Cargando…

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study

BACKGROUND: Since non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation monitoring, concerns of lower adherence and persistence to NOACs than vitamin K antagonists (VKAs) have been raised. Moreover, little is known on the frequency of permanent cessation and switching betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grymonprez, Maxim, Capiau, Andreas, Steurbaut, Stephane, Mehuys, Els, Boussery, Koen, De Backer, Tine L., Lahousse, Lies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558210/ https://www.ncbi.nlm.nih.gov/pubmed/36247477 http://dx.doi.org/10.3389/fcvm.2022.994085

Ejemplares similares

The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta‐analysis on the obesity paradox
por: Grymonprez, Maxim, et al.
Publicado: (2021)

Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023)

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023)

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
por: Grymonprez, M, et al.
Publicado: (2023)

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2023)

Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Community pharmacist counseling improves adherence and asthma control: a nationwide study
por: Putman, Barbara, et al.
Publicado: (2022)

Ghent Older People’s Prescriptions Community Pharmacy Screening (GheOP(3)S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care
por: Foubert, Katrien, et al.
Publicado: (2021)

Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
por: van Boven, Job FM, et al.
Publicado: (2014)

Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study
por: Chen, Pei-Ti, et al.
Publicado: (2019)

Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Salmasi, Shahrzad, et al.
Publicado: (2020)

Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)
por: Devroey, D, et al.
Publicado: (2014)

Treatment patterns for oral anticoagulants in older patients with atrial fibrillation: a retrospective, cross-sectional, nationwide study from Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2022)

Comparison of cerebral blood flow in subjects with and without chronic obstructive pulmonary disease from the population-based Rotterdam Study
por: Wijnant, Sara R A, et al.
Publicado: (2021)

Prevalence of Asthma and COPD and Blood Eosinophil Count in a Middle-Aged Belgian Population
por: Wijnant, Sara R. A., et al.
Publicado: (2019)

Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care
por: Harris, K, et al.
Publicado: (2013)

Correction to: Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2023)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
por: Adelakun, Adenike R, et al.
Publicado: (2023)

Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study
por: Wu, Hsin-Hsu, et al.
Publicado: (2022)

Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol
por: Antoine, Jérôme, et al.
Publicado: (2016)

SARS-CoV-2 Surveillance in Belgian Wastewaters
por: Janssens, Raphael, et al.
Publicado: (2022)

Comparison of medication adherence to different oral anticoagulants: population-based cohort study
por: Ingason, Arnar B, et al.
Publicado: (2023)

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation
por: Keithler, Andrea Nichole, et al.
Publicado: (2022)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

The genetic structure of the Belgian population
por: Van den Eynden, Jimmy, et al.
Publicado: (2018)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
por: Banerjee, Amitava, et al.
Publicado: (2020)

Contemporary survival and anticoagulation of patients with atrial fibrillation: A community based cohort study in China
por: Wei, Yong, et al.
Publicado: (2022)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
por: Johnson, Michelle E, et al.
Publicado: (2016)

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD‐AF registry
por: Seelig, Jaap, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v9aqncr4mb86tb21ttf5o3vt5f